Double-negative Prostate Carcinoma
📧 Sign up to get email alerts when something new happens for Double-negative Prostate Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer [Phase 2]
Phase 2 trial investigating erdafitinib combined with abiraterone acetate or enzalutamide in double negative prostate cancer; study terminat…